Ketones Supplementation and Postprandial Lipemia

NCT ID: NCT03729934

Last Updated: 2021-05-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-01

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study determines whether different forms of ketones supplemented prior to a meal lower the triglyceride (fat) content in the blood of overweight and obese individuals. Through a randomized crossover design, participants (n=15) will participate in each of the following three experimental groups (no treatment control, ketone ester, ketone salt), with a 5-14 day washout period between each experimental visit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Previous studies conducted by the investigative team in rodents show that male mice fed a diet containing 30% ketone ester (by kcals) results in greater fecal content and energy loss. While the investigators are unsure of the exact macronutrient content of the energy loss, the hypothesis is that the energy excretion is attributed to lower fat absorption. In the context of this study, it's hypothesized that ketone salts and ketone esters (both available commercially and used for a variety of health-related claims) will reduce the absorption of dietary fats leading to lower circulating triglyceride concentrations if consumed prior to a high-fat mixed meal. If the hypothesis is correct, ketones supplementation could become a valuable strategy to reduce the rise in circulating triglycerides often present in obesity. Triglyceride concentrations in the blood following a meal have been linked to development of cardiovascular disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Overweight and Obesity Overweight Triglycerides High

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

This arm receives no treatment control.

Group Type NO_INTERVENTION

No interventions assigned to this group

Ketone Ester

This arm receives 25 g ketone ester.

Group Type EXPERIMENTAL

Ketone Ester

Intervention Type DIETARY_SUPPLEMENT

This arm receives 25 g ketone ester.

Ketone Salt

This arm receives 25 g ketone salt.

Group Type EXPERIMENTAL

Ketone Salt

Intervention Type DIETARY_SUPPLEMENT

This arm receives 25 g ketone salt.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ketone Ester

This arm receives 25 g ketone ester.

Intervention Type DIETARY_SUPPLEMENT

Ketone Salt

This arm receives 25 g ketone salt.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Overweight or obese men as defined by a BMI of greater than or equal to 25 kg/m2, but less than 35 kg/m2
* Between the ages of 25 and 45 years
* Fasting triglyceride levels less than 250 mg/dL

Exclusion Criteria

* Participates in regular physical activity (≥3 days/week at 30 minutes or more per day)
* Diagnosed cardiovascular disease or metabolic disease (type 1 or type 2 diabetes)
* Currently following a low carbohydrate (\<100 g/day) diet
* Lost greater than or equal to 5% body weight over the last 2 months
* Alcohol/smoking/antibiotics
Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eric P. Plaisance

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KBS2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Zhongshan Ketogenic Diet Study 1
NCT07117903 RECRUITING NA